The Germany legal cannabis market size is expected to reach USD 85.6 million by 2030, growing a CAGR of 14.9% over the forecast period, according to a new report by Grand View Research, Inc. Factors such as rising social acceptance of cannabis, growing medical applications of cannabis, increasing R&D & technological innovation, and the introduction of new cultivation technologies are expected to drive the cannabis industry in the country. For instance, in February 2024, according to data published in Reuters, 4.5 million individuals are estimated to use cannabis in Germany.
Furthermore, favorable government initiatives and reimbursement policies fuel the market growth. For instance, according to data published by the Federal Union of German Associations of Pharmacists (ABDA), the number of prescriptions for medical cannabis for Statutory Health Insurance (SHI)-insured patients in Germany was 338,500 in 2022. Furthermore, according to the same source, 14,840 Kg of cannabis was delivered to pharmacies for medicinal purposes in 2022. Moreover, growing awareness among people regarding the therapeutic applications of cannabis and the launch of online cannabis prescription platforms drive market growth. For instance, in September 2023, Cantourage Group SE, a Berlin-based company, introduced Telecan, a telemedicine platform for medical cannabis, under the guidance of Florian Wesemann, a medical doctor. The platform offers a simple and convenient way for potential patients to access cannabis therapy. In recent years, there has been a significant rise in the usage of cannabis and its derivatives in Germany. The medical application of CBD has gained immense popularity, leading to the development of policies for its distribution and use by the government. Moreover, conferences and various events being organized for cannabis industry leaders drive market growth. For instance, the International Cannabis Business Conference was to be held in Berlin in April 2024, Germany’s biggest annual gathering of influential political and cannabis business leaders. The cannabis industry has witnessed the development of new techniques and technologies that aid in its cultivation, and these advancements are expected to boost market growth. The demand for technologically advanced cannabis production has led to the optimization of resources by cultivators. This, coupled with the increased utilization of hemp and marijuana in various sectors, such as personal care & cosmetics, pharmaceuticals, nutraceuticals, and food, & beverages, has impelled market growth. In addition, the use of cannabis and its derivatives by various businesses as a raw material for manufacturing products is projected to drive market growth over the forecast period. List of Key Players in the Germany Legal Cannabis Market
Germany Legal Cannabis Market Report Highlights
Details Market size value in 2024 USD 37.2 Million Revenue forecast in 2030 USD 85.6 Million Growth rate CAGR of 14.9% from 2024 to 2030 Base year for estimation 2023 Actual data 2018 - 2023 Forecast data 2024 - 2030 Request For A Free Consultation@ https://www.grandviewresearch.com/request-free-consultation/457511/rfc Germany Legal Cannabis Market Segmentation Grand View Research has segmented the Germany legal cannabis market based on source, derivatives, and end-use: Germany Legal Cannabis Source Outlook (Revenue, USD Million, 2018 - 2030)
0 Comments
![]() The global Toys And Games Market size is expected to reach USD 439.91 billion by 2030, growing a CAGR of 4.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. Sales increased as the pandemic spread. Toy sales increased in 2020, with games & puzzles, dolls & action figures, and outdoor plays being the most popular categories. The use of weather-related items was a big aspect of outdoor activity. Sleds, snow-coloring toys, inflatables, and tools for building snow structures flew off the shelves. Due to the ease of accessibility, a large range of products, and competitive pricing, consumers are increasingly purchasing toys and games through the e-commerce channel. Furthermore, internet portals assist customers 24 hours a day, seven days a week, and offer a wide range of products to choose from, as well as substantial discounts on branded products. In addition, families wanted to spread a little extra cheer during the pandemic, thus retailers had a successful holiday season in 2020. Sports toys, such as skateboards and scooters, outperformed fashion dolls and accessories, as well as building sets like Lego. In 2020, due to increased traffic to its website on Black Friday, Lego had to construct a virtual wait for online consumers. The popularity of 3D and 4D puzzles has sparked creativity and excitement in the industry. These puzzles provide a more immersive experience, higher levels of engagement, and possibly even educational advantages. A Canadian company called Wrebbit Puzzle Inc. focuses on 3D puzzles and creates a wide variety of puzzles with different themes, such as Harry Potter, Game of Thrones, and Lord of the Rings. The business introduced its Central Perk, a 440-piece 3D jigsaw puzzle, in April 2021, which was based on the television series, Friends. Due to the rising environmental awareness and consumer concern, as well as a growing trend toward eco-friendly and socially responsible products, the market is currently experiencing increased demand for sustainable games and puzzles. Market players have been addressing this trend by creating and promoting eco-friendly products, utilizing sustainable resources, and putting into practice eco-friendly manufacturing and distribution procedures. For instance, to reduce its impact on the environment, a U.S.-based corporation called Mattel, Inc. always attempts to optimize its resource use. Related Press Release@ Toys And Games Market Report Toys And Games Market Report Highlights
Details Market size value in 2024 USD 341.1 Billion Revenue forecast in 2030 USD 439.9 Billion Growth rate (revenue) CAGR of 4.3% from 2024 to 2030 Actual data 2018 - 2023 Forecast period 2024 - 2030 Request For A Free Consultation @ https://www.grandviewresearch.com/request-free-consultation/6091/rfc Toys And Games Market Segmentation Grand View Research has segmented the global toys and games market based on product, application, distribution channel, and region: Toys And Games Product Outlook (Revenue, USD Billion, 2018 - 2030)
The global Medical Tourism Market size is expected to reach USD 75.3 billion by 2030, growing at a CAGR of 25.22% from 2023 to 2030, according to a new report by Grand View Research, Inc. Cardiovascular treatment (coronary artery bypass graft and heart valve transplantation), dental treatment (veneers, implants, and crowns), cosmetic treatment (breast implants and facelifts) and orthopedic treatment (knee & hip reconstruction and spinal surgery), are among the most frequently performed procedures for medical tourists.
Most elective surgeries, such as cosmetic surgery, certain dental surgeries, fertility treatments, and weight loss surgeries, are not covered by insurance companies in the U.S. Limited availability or lack of insurance coverage drives people to seek procedures in countries such as Thailand, India, and Malaysia. Cosmetic surgeries in most countries are considered elective, and therefore, are not covered under health insurance. This results in interested patients seeking treatment options abroad. Patients can save treatment costs substantially by traveling to countries where such services are provided at lower costs. For instance, according to the American Society of Plastic Surgeons, a breast augmentation procedure average costs around USD 4,500 to USD 5,000 for an individual in the U.S., compared to around USD 3,000 to USD 4,000 in Malaysia. In addition, the cost of IVF treatment in the U.S. is between USD 12,000 and USD 25,000, whereas in Thailand, it is priced at around USD 6,200 and USD 12,000. This price difference has led to an increase in patient arrivals in Asian countries. Moreover, the option of combining wellness and medical trips with outstanding clinical facilities and traditional medicine therapies is driving many patients to prefer this option. China has emerged as a key destination for travelers seeking stem cell therapies. Stem cell research is banned in several countries. However, it is legal in China and hence tourists consider China for undergoing it legally. The China market is growing rapidly, owing to a globally expanding middle class, an aging population, and an increasing demand for cosmetic surgery. Advertising is critical in gaining new clients. Similar to many other privately driven sectors, medical tourism requires advertising exposure. Advertising on websites has become the primary source of information for health travelers. Therefore, having more recognized hospitals enhances a country's global standing. The phenomenal increase in health tourism is being accompanied by the establishment of Joint Commission International (JCI)-accredited health centers. Singapore, for example, has numerous specialist clinics and 22 hospitals, and specialized centers accredited by the JCI, all of which provide high-quality healthcare services. Due to the availability of state-of-the-art facilities, the country is an attractive medical tourism destination in terms of accommodation and housing alternatives. However, the COVID-19 pandemic adversely impacted the market for medical tourism. It shook the travel and tourism industry to its foundations. Prominent hospital service providers suffered heavy losses in 2020, as COVID-19 pandemic travel restrictions negatively affected health services aimed at medical tourists. A majority of the workforce in this sector suffered economic losses. A sharp decline in the number of patient arrivals due to travel bans and strict regulations heavily impacted the overall market. Related Press Release@ Medical Tourism Market Report Medical Tourism Market Report Highlights
Details Market size value in 2023 USD 15.6 billion Revenue forecast in 2030 USD 75.3 billion Growth rate CAGR of 25.2% from 2023 to 2030 Base year for estimation 2022 Historical data 2018 - 2021 Forecast period 2023 - 2030 Request For A Free Consultation@ https://www.grandviewresearch.com/request-free-consultation/1119/rfc Medical Tourism Market Segmentation Grand View Research has segmented the global medical tourism market based on treatment type, service provider, and country: Medical Tourism Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
![]() The U.S. Revenue Cycle Management Market size is expected to reach USD 308.2 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 10.3% from 2023 to 2030. Growing data siloes emerging from multiple healthcare functionalities and departments are driving the need to consolidate and streamline unorganized workflows to boost efficiency and productivity in healthcare organizations. Furthermore, the growing trend of digital health and widespread adoption of healthcare IT solutions are anticipated to accelerate market growth. The market growth in the U.S. can also be attributed to the increasing healthcare IT spending and the growing trend of outsourcing RCM systems and services. Healthcare systems in the U.S. are undergoing significant transformations and readily adopting electronic processes for claims and reimbursement management. The presence of numerous renowned healthcare facilities, increasing healthcare awareness and spending, and the growing digital literacy are expected to support the growth of the market. Favorable regulatory reforms from government agencies and regular technological advancements by market players are expected to boost market growth over the forthcoming years. The growing need for regular technological advancements is driving market players to revise their product development strategies to improve provider-patient relationship in healthcare facilities. Key participants are focusing on collaborations and strategic partnerships with other market players to combine expertise and grow their business footprint. For instance, in January 2020, R1 RCM, Inc. entered into a strategic partnership with Rush University System for Health (RUSH) to achieve revenue cycle performance excellence and boost innovation in healthcare. As per the agreement, the platform by R1 RCM would be integrated with RUSH’s Epic EMR workflow, which uses enterprise-wide performance analytics and intelligent automation to improve the company’s current revenue cycle operations. In addition, the collaboration would aid R1 RCM to launch its innovation lab, which focuses on value-based care and incorporates advanced analytics to educate other healthcare institutions in preparing for the future healthcare workforce. This partnership is expected to enable significant improvements in serving patients and financial results in the Chicago metropolitan area. Market players are introducing innovative product solutions to expand their product portfolio and grow their clientele. For instance, in June 2019, Homecare Homebase (HCHB) introduced a new RCM tool that would reduce the burden related to staffing and time-consuming administrative functions, which often restrict the home health agencies from spending more quality time with patients. Moreover, this new tool offers greater transparency into the murky RCM process that is suitable for agency management, by making use of HCHB dashboards and analytical systems. This new tool makes use of extensive knowledge of the billing process, which aids in achieving and maintaining high collection days and reducing outstanding days in accounts receivable (AR), enabling more time with patients. List of Key Players of U.S. Revenue Cycle Management Market
U.S. Revenue Cycle Management Market Report Highlights
U.S. Revenue Cycle Management Market Segmentation Grand View Research, Inc. has segmented the U.S. revenue cycle management market on the basis of end user, product type, component, delivery mode, physician specialty, sourcing, and function: U.S. Revenue Cycle Management End-user Outlook (Revenue, USD Billion, 2016 - 2030)
![]() The global Digital Pathology Market size is expected to reach USD 1.73 billion by 2030, registering a CAGR of 8.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is anticipated to witness exponential growth owing to rising prevalence of chronic diseases aided by increasing demand for accurate diagnostics. Chronic diseases affect nearly one in every three adults. Whereas, according to the CDC, in the U.S., approximately, 51.8% of adults have at least one chronic disease. Digital pathology, including molecular tissue profiling, biobanking, tissue microarray analysis, and molecular biology, plays an important role in the drug development pipeline and companion diagnostics. Growing demand for high-quality tissue samples in tissue-based biomarker research is expected to drive technology adoption over the forecast period. Increasing adoption of telepathology with the launch of newer versions of the technology, such as in June 2022, Tribun Health launched TeleSlide Patho 5, an online telepathology platform used for providing clinical and timely expertise to patients. Moreover, the market is expected to see intense competition in the near future as companies adopt more stringent strategies to compete. Moreover, technological advancements, such as the digitization of pathology lab makes the specialty more efficient, the specimen more reproducible, and pathologists' work easier. In past few years, several breakthrough advancements have provided a significant boost to market growth. For instance, in September 2021, Paige received FDA approval for Paige Prostate, an AI solution for the detection of prostate cancer. The product is the first AI-enabled pathology product to gain marketing authorization. This was further followed by the collaboration of F. Hoffmann-La Roche Ltd. with Ibex in October 2021 for the development of artificial intelligence-based pathology applications for the improvement of patient care. Furthermore, major players are adopting strategies like collaborations and partnerships with a focus on technological advancements, such as robotic light microscopy, digital imaging, multiple fiber optic communications, and computerization, to enhance the adoption of digital pathology. For instance, in December 2022, Deciphex launched Patholytix 3.0, a Digital Research Pathology Platform with an aim to revolutionize tools available for research pathologists and designed to overcome the limits of LIMS software that allows users to effectively manage associated data and samples. Furthermore, with the launch, the company also highlighted features of the new platform that impact workflow and offer simpler and more expedient report creation. List of Key Players in the Digital Pathology Market
Digital Pathology Market Report Highlights
Digital Pathology Market Segmentation Grand View Research has segmented the global digital pathology market based on product, type, application, end-use, and region: Digital Pathology Product Outlook (Revenue, USD Billion, 2018 - 2030)
![]() The global Menopause Market size is expected to reach USD 24.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.33% from 2023 to 2030. Increasing awareness regarding menopause-associated health aspects, rising prevalence of post-menopausal syndrome, and high adoption of women’s health apps are expected to boost market growth during the forecast period. Key players in the region are conducting campaigns to create awareness about women’s health and the role of dietary supplements in easing the transition through it. For instance, in October 2021, Klassen, a reproductive mental health specialist, started the campaign, Let’s Talk Menopause, to make women aware of menopausal symptoms and treatment. The campaign started in 200 subway stations in New York and is its first-of-kind campaign in the U.S. Rising research supporting the benefits of the dietary supplements than the HRT is projected to drive the market. There are various dietary supplements available in the market containing ingredients such as soy isoflavones, black cohosh, red clover, and amberen. Manufacturers are involved in the launch of new products for managing menopausal symptoms. For instance, in December 2021, Doctor’s Seaweed’s Weed and Wonderful, a U.K.-based food startup, launched seaweed-based supplements for menopause, which are organic and contain nutrients such as iodine and isoflavones. The pandemic slowed down the market growth as the focus of pharmaceutical companies shifted towards the production of drugs and immune supplements for COVID-19. However, the demand for OTC pharma products and dietary supplements increased during the later phase of 2020 because of the postponement of hormonal replacement therapies, delays in physician’s appointments, and the easy availability of OTC drugs from online channels and retail pharmacies. The market is now stabilizing owing to the ease in the restrictions and the rising awareness regarding menopausal manifestation. Related Press Release@ Menopause Market Report Menopause Market Report Highlights
Menopause Market Segmentation Grand View Research has segmented the global menopause market based on treatment and region: Menopause Treatment Outlook (Revenue, USD Million, 2018 - 2030)
![]() The global Herpes Simplex Virus Treatment Market size is expected to reach USD 4.08 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 8.1% from 2024 to 2030. The growth of the market is attributed to factors such as increasing prevalence of herpes infection among the population, growing awareness about the disease globally, rising geriatric and immunocompromised population, and an increasing demand to develop novel treatment options to meet the demand for herpes infection therapeutics. Moreover, public-private initiatives are further expected to fuel the growth of the market. According to the WHO, in 2020, nearly 491.5 million people were suffering from genital herpes caused by the herpes simplex virus 2, and several billion people have herpes simplex virus 1 infection. Although the infection is typically asymptomatic, those who have it are capable of easily transmitting the virus to another person through contact. Furthermore, nearly 80 percent of the global population is a carrier of herpes. This is creating an opportunity for the growth of herpes infection treatment drugs. Research initiatives and increasing collaborations between research organizations are facilitating the development of novel treatment alternatives against viruses, which is anticipated to boost market growth. In January 2020, a research collaboration between scientists from the EPFL in Lausanne, Switzerland, the University of Geneva (UNIGE), and the University of Manchester led to the development of novel antiviral materials, virucides, made from sugar that show promise for the treatment of herpes simplex (cold sore virus). The development of virucides from sugar has facilitated the arrival of an innovative antiviral drug, which aids treatment without being toxic to humans. Key players operating in the market are focusing on developing novel and innovative products to meet the increasing demand for providing effective therapeutics. With the increasing demand for effective therapeutics, companies are engaged in developing novel and innovative medicines against infection. For instance, in July 2021, a Phase III study of pritelivir, a novel drug by AiCuris Anti-infective Cures AG, which is a German pharmaceutical company, was commenced, post receiving encouraging Phase II interim results from the Phase II/III trial. This leading compound is developed to treat immunocompromised patients with mucocutaneous HSV infections that are acyclovir-resistant. It was granted Breakthrough Therapy Designation by the U.S. FDA in June 2020. The regulatory support for innovative therapies is projected to improve the number of new drugs entering the market, facilitating enhanced treatment rates, and thereby accelerating market growth. List of Key Players in Herpes Simplex Virus (HSV) Treatment Market
Herpes Simplex Virus Treatment Market Report Highlights
Details Market size value in 2024 USD 2.56 billion Revenue forecast in 2030 USD 4.08 billion Growth rate CAGR of 8.1% from 2024 to 2030 Base year for estimation 2023 Historical data 2018 - 2022 Forecast period 2024 - 2030 Request For A Free Consultation @ https://www.grandviewresearch.com/request-free-consultation/453481/rfc Herpes Simplex Virus Treatment Market Segmentation Grand View Research has segmented the global herpes simplex virus treatment market based on type, drug, vaccine, route of administration, end-use, and region: Herpes Simplex Virus Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
![]() The global Powered Wheelchair Market size is expected to reach USD 3.21 billion by 2030, registering a CAGR of 6.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The primary factors driving the market are the increasing disability rates, a growing aging population, technological advancements, and government initiatives and regulations. According to the Centers for Disease Control and Prevention (CDC), around 27%, 1 in every 4 adults in the United States have some type of disability out of which 12.1% of adults in the United States struggle significantly to walk or climb stairs due to mobility impairment. In the United States, there are an estimated 3.3 million wheelchair users, and this figure is rising annually. Due to the rise in the baby boomer group who has a high need for wheelchairs, the demand for wheelchairs is rising. Moreover, the rising customization offered by several players is anticipated to boost the market. Wheelchairs are being designed with a greater focus on customization to meet individual needs and preferences. Manufacturers are offering options for adjustable seating, backrests, armrests, and other features, allowing users to have a personalized and comfortable experience. The COVID-19 outbreak negatively impacted the market in the initial phase of 2020. Due to lockdowns and travel and manufacturing restrictions, the pandemic caused disruptions in the world's supply-chain networks. This has affected the production and distribution of wheelchairs and their components, leading to potential delays in manufacturing and delivery. However, the market recovered soon as there was demand was a surge in demand for healthcare equipment, including wheelchairs, in medical facilities. Hospitals and clinics required additional equipment to manage patients with mobility issues, which contributed to an increased demand for both manual and powered wheelchairs. List of Key Players in Powered Wheelchair Market
Powered Wheelchair Market Report Highlights
Details Market size value in 2024 USD 2.15 billion Revenue forecast in 2030 USD 3.21 billion Growth rate CAGR of 6.9% from 2024 to 2030 Actual data 2018 - 2023 Forecast period 2024 - 2030 Request For A Free Consultation @ https://www.grandviewresearch.com/request-free-consultation/452588/rfc Powered Wheelchair Market Segmentation Grand View Research has segmented the global powered wheelchair market based on age category, product, portability, end-use, and region: Powered Wheelchair Age Category Outlook (Revenue, USD Million, 2018 - 2030)
![]() The global Antibiotic Resistance Market size is expected to reach USD 12.48 billion by 2030, registering a CAGR of 5.27% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rise in the number of antibiotic-resistant infections due to misuse or overuse of antibiotics is a major factor attributing to market growth. Moreover, the increasing patient base across the globe and high costs associated with the treatment of diseases is anticipated to boost the market growth over the forecast period. The prevalence of gram-negative infections is increasing at an alarming rate. These infections have lesser treatment options available in the market. The high unmet needs result in high demand for new therapies and, therefore, small and medium-sized pharmaceutical companies are actively involved in the development of novel treatment options. Moreover, the government and other organizations are also aiding research activities to drive the development of innovative therapies. Multiple mid-level biotechnology companies have entered the arena with targeted therapies for antibiotic-resistant infections. Various manufacturers are developing therapies, especially for drug-resistant infections, that target a smaller population subset. The U.S. government in alliance with BARDA is supporting several companies to boost the development of new therapies for antibiotic-resistant diseases. BARDA has also been associated with pharmaceutical companies such as GSK; Tetraphase; Basilea; Astra Zeneca; and many more. Many countries and international organizations have formed dedicated groups or alliances to monitor and study the pattern of drug-resistant infections. For instance, the WHO has introduced the Global Antimicrobial Resistance Surveillance System (GLASS) to monitor antibiotic-resistant infections at a global level. Similarly, the Public Health Agency of Canada has introduced the Canadian Antimicrobial Resistance Surveillance System (CARSS) to study drug-resistant infections pattern at the country level. However, according to a review published by WHO in March 2023, the antibiotics pipeline activities are limited, with only 12 new antibiotics being approved between 2017 and 2021. The review further stated that there are only 27 new candidates under development, out of which only 6 are considered “innovative” enough to be capable of overcoming antibiotic resistance as defined by WHO. Related Press Release@ Antibiotic Resistance Market Report Antibiotic Resistance Market Report Highlights
Details Market size value in 2024 USD 9.17 billion Revenue forecast in 2030 USD 12.48 billion Growth rate CAGR of 5.27% from 2024 to 2030 Base year for estimation 2023 Historical data 2018 - 2022 Forecast period 2024 - 2030 Request For A Free Consultation @ https://www.grandviewresearch.com/request-free-consultation/5467/rfc Antibiotic Resistance Market Segmentation Grand View Research has segmented the global antibiotic resistance market based on disease, pathogen, drug class, mechanism of action, distribution channel, and region: Antibiotic Resistance Disease Outlook (Revenue, USD Million, 2018 - 2030)
![]() The global Liver Metastases Treatment Market is expected to reach USD 2.66 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 7.3% from 2024 to 2030. Rising prevalence of target disease, advanced stage diagnosis for cancer in developing countries, and increasing number of products approvals is expected to drive the industry growth. Colorectal cancer, breast cancer, and lung cancer are some of the key types that metastasize to the liver. The incidence of colorectal cancer is expected to increase from 1.88 million in 2020 to 2.45 million in 2030. Whereas the incidence of breast cancer is expected to increase from 2.26 million in 2020 to 2.74 million in 2030. The rising incidence of these primary indications is expected to drive space growth. Majority of the cancer cases in low and middle-income countries are diagnosed at advanced stages where the availability of therapeutic options is low. The lack of availability of early diagnostics methods combined with uncertain reimbursement scenario for diagnostics are major reasons for delayed diagnosis. The advanced/metastatic stage of diagnosis provide lucrative growth opportunities in this space. On the other hand, if cancers are diagnosed at advanced stages particularly in developing nations and LMICS, the treatment rate at such advanced stages is significantly less, due to unavailability of products and proper reimbursement. This factor is expected to restrain space growth. List Of Key Players in the Liver Metastases Treatment Market
Liver Metastases Treatment Market Report Highlights
Details Market size value in 2024 USD 1.74 billion Revenue forecast in 2030 USD 2.66 billion Growth rate CAGR of 7.3% from 2024 to 2030 Base year for estimation 2023 Historical data 2018 - 2022 Forecast period 2024 - 2030 Request For A Free Consultation @ https://www.grandviewresearch.com/request-free-consultation/454161/rfc Liver Metastases Treatment Market Segmentation Grand View Research has segmented the global liver metastases treatment market report based on treatment type, primary cancer, distribution channel, and region: Liver Metastases Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
|
Archives
October 2023
|